PlainRecalls
FDA Drug Low Class III Terminated

Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland

Reported: March 5, 2014 Initiated: February 19, 2014 #D-1090-2014

Product Description

Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland

Reason for Recall

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Details

Recalling Firm
Gilead Sciences, Inc.
Units Affected
39,223 bottles
Distribution
Nationwide including Puerto Rico.
Location
Foster City, CA

Frequently Asked Questions

What product was recalled?
Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland. Recalled by Gilead Sciences, Inc.. Units affected: 39,223 bottles.
Why was this product recalled?
Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 5, 2014. Severity: Low. Recall number: D-1090-2014.